BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9313059)

  • 1. [Ciprofloxacin--a highly effective drug from the fluoroquinolone group].
    Iakovlev VP
    Antibiot Khimioter; 1997; 42(6):4-14. PubMed ID: 9313059
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone pharmacodynamics and efficacy.
    Doern GV; Tillotson GS
    Chest; 2001 Jul; 120(1):319-20. PubMed ID: 11451862
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between ciprofloxacin and rifampin.
    Temple ME; Nahata MC
    Ann Pharmacother; 1999; 33(7-8):868-70. PubMed ID: 10466918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.
    Jeffres MN; Shuster JE; Barclay SM
    Ann Pharmacother; 2011 Jun; 45(6):824-5. PubMed ID: 21666093
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
    Nouvet G; Benmessaoud K
    Drugs; 1995; 49 Suppl 2():423-5. PubMed ID: 8549386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ciprofloxacin treatment for pregnant or lactating women and children?].
    Aizenstein O; Lehavi O; Tur-Kaspa I
    Harefuah; 1997 Feb; 132(4):283-8. PubMed ID: 9153900
    [No Abstract]   [Full Text] [Related]  

  • 7. Do we need an intravenous fluoroquinolone?
    Maddix DS; Warner L
    West J Med; 1992 Jul; 157(1):55-9. PubMed ID: 1413744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial efficacy and pharmacokinetic studies of ciprofloxacin on Pasteurella multocida infected rabbits.
    Hanan MS; Riad EM; el-Khouly NA
    Dtsch Tierarztl Wochenschr; 2000 Apr; 107(4):151-5. PubMed ID: 10829566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level ciprofloxacin resistant gonorrhoea imported from Russia.
    Lewis DA; Brook MG; Shafi MS
    Genitourin Med; 1997 Aug; 73(4):325-6. PubMed ID: 9389968
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba.
    Das S; Goyal R; Ramachandran VJ; Gupta S
    Ann Trop Paediatr; 2005 Sep; 25(3):211-2. PubMed ID: 16156987
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.
    Nachamkin I; Ung H; Li M
    Emerg Infect Dis; 2002 Dec; 8(12):1501-3. PubMed ID: 12498672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin monotherapy and bacterial keratitis.
    Katz HR
    Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India.
    Rattan A; Kumari S; Khanna N; Pandhi RK; Ray K; Bala M; Misra RS
    Sex Transm Infect; 1998 Jun; 74(3):229. PubMed ID: 9849566
    [No Abstract]   [Full Text] [Related]  

  • 15. Ciprofloxacin: a warning for clinicians.
    Lothstein LM
    Conn Med; 2002 Jul; 66(7):423-6. PubMed ID: 12181866
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging drug resistance and vaccination for typhoid fever.
    Atkins BL; Gottlieb T
    JAMA; 1998 Feb; 279(8):579; author reply 580. PubMed ID: 9486743
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
    Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
    Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Iakovlev VP; Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2004; 49(8-9):57-65. PubMed ID: 15727148
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; CardaƱo RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.